|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
On a per-share basis, the Nashua, New Hampshire-based company said it had a loss of 6 cents. The imaging and early cancer detection company posted revenue of $6.2 million in the period. In the final minutes ...
Google stock Alphabet set up a new buy point. Tech, retail, health care and banking stocks gave the major indexes nice gains in afternoon trading. Chinese ADRs fell.
YY Inc (YY) posts better-than-expected earnings and revenues in second-quarter 2018, courtesy of robust contribution from the live streaming segment.
On a per-share basis, the Guangzhou, China-based company said it had a loss of 32 cents. Earnings, adjusted for non-recurring costs, were $2.03 per share. The results exceeded Wall Street expectations. ...
Exelixis (EXEL) generated net revenues of $186.1 million in the second quarter of 2018 compared to $99 million in the second quarter of 2017. In the first half of 2018, Exelixis reported revenues of $399.8 million compared to $179.9 million in the first half of 2017. In the first half of 2018, Exelixis generated revenues of $280.1 million, reflecting ~92% YoY (year-over-year) growth.
Ionis Pharmaceuticals (IONS), a leading RNA-targeted therapeutics developing company, aims to develop best-in-class drugs for life-threatening diseases. Ionis commercializes the approved products in collaboration with other pharmaceuticals companies. Ionis reported revenues of $118 million in Q2 2018, a 5% increase in year-over-year (or YoY) revenues as compared to the second quarter of 2017.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does BGC Partners (BGCP) have what it takes? Let's find out.
MARKET PULSE Shares of iCAD Inc. (icad) were indicated up over 30% in premarket trade Wednesday, after the provider of technology for use in cancer detection announced Food and Drug Administration clearance of its latest artificial intelligence software product.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting INCY. Over the last month, growth of ETFs holding INCY is favorable, with net inflows of $19.82 billion. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing.
Of course, it's difficult to predict which technologies will change our world and how long their influence will last. On top of that, it's often a challenge for investors to identify investable opportunities associated with these groundbreaking technologies. The Morningstar Exponential Technologies Index focuses on finding high-growth companies that are in the early stages of developing technologies that are expected to have a broad impact on society and transform how we live and work.
The only name of consequence that headed meaningfully higher was DISH Network (NASDAQ:DISH), up 14.5% in response to its second-quarter report. Heading into the new trading week, those appear to be Entergy (NYSE:ETR), Incyte (NASDAQ:INCY) and SL Green Realty (NYSE:SLG). When Entergy reported better-than-expected second-quarter earnings last week, the stock jumped.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting BGCP. Over the last one-month, outflows of investor capital in ETFs holding BGCP totaled $603 million.
PDF Solutions (PDFS) delivered earnings and revenue surprises of -66.67% and -8.58%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
The San Jose, California-based company said it had a loss of 7 cents per share. Earnings, adjusted for stock option expense and non-recurring costs, were 2 cents per share. The provider of software and ...
BGC Partners (BGCP) delivered earnings and revenue surprises of 7.14% and 2.35%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?